We have located links that may give you full text access.
Differential ethanol intake in high and low responders to novelty.
Behavioural Pharmacology 1995 November
The aim of the study was to determine whether high responders (HR) and low responders (LR) to novelty, selected from an outbred Wistar rat population, show differences in ethanol consumption. HR and LR differ in catecholaminergic activity in the nucleus accumbens as well as in brain sensitivity to corticosteroids, biological features believed to play a role in ethanol consumption. Due to these differences it was predicted that HR would consume less ethanol and show less preference than would LR. Animals were maintained on a schedule of alternative day presentation of ethanol. Starting with an ethanol presentation of 2% in a free choice with water, ethanol solutions were presented and increased by increments of 1% every second day. HR showed a preference for water over ethanol, whereas LR showed no preference for water over ethanol. In order to determine intake and preference stability, animals were switched to daily presentations of ethanol and maintained on a 10% ethanol solution for 18 days. Individual-specific differences remained stable throughout the entire period. Given the available knowledge about biological differences between HR and LR, the present data indicate that these animals are good models for the study of the mechanisms underlying individual-specific differences in the behavioral responses to ethanol.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app